Correlation Between Spyre Therapeutics and Discover Financial
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Discover Financial at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Discover Financial into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and Discover Financial Services, you can compare the effects of market volatilities on Spyre Therapeutics and Discover Financial and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Discover Financial. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Discover Financial.
Diversification Opportunities for Spyre Therapeutics and Discover Financial
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Spyre and Discover is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Discover Financial Services in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Discover Financial and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Discover Financial. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Discover Financial has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Discover Financial go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and Discover Financial
Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Discover Financial. In addition to that, Spyre Therapeutics is 1.51 times more volatile than Discover Financial Services. It trades about -0.11 of its total potential returns per unit of risk. Discover Financial Services is currently generating about -0.03 per unit of volatility. If you would invest 17,400 in Discover Financial Services on December 27, 2024 and sell it today you would lose (1,149) from holding Discover Financial Services or give up 6.6% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Spyre Therapeutics vs. Discover Financial Services
Performance |
Timeline |
Spyre Therapeutics |
Discover Financial |
Spyre Therapeutics and Discover Financial Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Spyre Therapeutics and Discover Financial
The main advantage of trading using opposite Spyre Therapeutics and Discover Financial positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Discover Financial can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Discover Financial will offset losses from the drop in Discover Financial's long position.Spyre Therapeutics vs. Plexus Corp | Spyre Therapeutics vs. Molecular Partners AG | Spyre Therapeutics vs. Allient | Spyre Therapeutics vs. Jabil Circuit |
Discover Financial vs. Visa Class A | Discover Financial vs. PayPal Holdings | Discover Financial vs. Capital One Financial | Discover Financial vs. Upstart Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |